HIF1A and type 2 diabetes mellitus: In the case of type-2 diabetes mellitus (T2DM), abnormal metabolic phenotype of HIF-1α destabilization is noted as less tolerance to hypoxia and rapid HF progression and its stabilization by Molidustat was effective in the treatment of diabetic heart from post-ischemic recovery [231].